Banks Bourne Delivers Keynote at SEBIO

CHARLOTTE, N.C., November 20, 2015 – Bourne Partners CEO and Senior Managing Director, Banks Bourne, delivered the keynote address at the 17th annual Southeast Bio (SEBIO) Investor & Partnering forum in Charleston, South Carolina last week.  More than 300 regional biotech and medtech investors, corporate executives, university representatives, entrepreneurs, and service providers attended the event this year. 

Bourne’s keynote addressed macro healthcare trends in the US, M&A market trends, and a value creation case study of Covis Pharmaceuticals. 

“It was a great audience and really enjoyable conference.  I appreciate the opportunity to discuss what’s going on in the industry and share more about the incredible work my team is doing,” said Bourne. 

SEBIO is an annual forum, attracting thought leaders and innovators from across the country. To date, the more than 200 later stage and 165 early stage companies that participated in previous SEBIO Investor & Partnering Forums have raised more than $2.5 billion in public and private funding.

About Bourne Partners (BP)
Headquartered in Charlotte, N.C., Bourne Partners is a financial advisory, investment and consulting firm founded in 2001 that focuses solely on fulfilling the unique needs of established healthcare and pharmaceutical companies across the globe. Originally founded as a pharmaceutical investment firm, BP has evolved its service offerings in an effort to form enduring relationships with the healthcare and consumer companies it chooses to serve.  In addition, through its Bourne Partners Alternative Assets platform (BPAA), BP invests directly in healthcare and consumer companies and invests opportunistically in other companies where it sees compelling long-term return characteristics. BPAA takes either majority positions or co-investment positions alongside other private equity firms with whom BPAA has longstanding relationships. BPAA seeks to add value to its partner company and fund investments by applying its network of strategic relationships (both private equity and industry relationships), advisory and consulting expertise, and operating experience to generate a positive outcome for management, employees, and investors.

For additional information, visit

About the SEBIO Investor & Partnering Forum
Southeast BIO (SEBIO) is a regional non-profit organization that fosters the growth of the life sciences industry in the Southeastern United States through efforts that promote entrepreneurship and bring together the key players active in the development of the industry. SEBIO’s geographic footprint includes Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee and Virginia. We focus on key industries within the life sciences, including: bio/pharma, medical devices and technology, agricultural biotechnology, animal health, bioinformatics and biomaterials. 

Receive Your Report By Email